Author

Santiago Ferrer-Bazaga

GlaxoSmithKline (Spain)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alfonso Mendoza-LosanaiD· 1 shared María Pilar Arenaz-CallaoiD· 1 shared Pablo GamalloiD· 1 shared Rubén González del Río· 1 shared Santiago Ramón‐GarcíaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alfonso Mendoza-LosanaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintMay 10, 2026

OPTIKA, a new high content kill-kinetic assay to longitudinally assess in vitro drug combinations against Mycobacterium tuberculosis

María Pilar Arenaz-Callao, Pablo Gamallo, Alfonso Mendoza-Losana…·Santiago Ramón‐García

The paper introduces OPTIKA, a high-throughput time-kill assay for assessing drug combinations against Mycobacterium tuberculosis, showing it outperforms traditional methods by over 1000-fold.

DOI 10.64898/2026.05.10.724062

experimental assaydrug response / drug discovery

𝕏 PostBluesky